| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/07/1999 | US5948795 Benzothiopene compounds, and uses and formulations thereof |
| 09/07/1999 | US5948784 Nephritis |
| 09/07/1999 | US5948780 Administering a metalloproteinase inhibitor |
| 09/07/1999 | US5948767 Transport of active material into cells; drug delivery |
| 09/07/1999 | US5948761 For treating conditions characterized by high levels of extracellular fluid; human or veterinary medicine |
| 09/07/1999 | US5948759 Factor VII fragment 82-128 and its use in blood-clotting disorders |
| 09/07/1999 | US5948435 Methods of regulating CETP genes, enzymes and other compound, and pharmaceutical composition therefor |
| 09/07/1999 | US5948402 Method of using IL-11 for treating antibiotic induced diarrhea |
| 09/07/1999 | US5947708 Axial flow valve system for linear compressor |
| 09/07/1999 | CA2168563C Benzopyrans and pharmaceutical compositions containing them |
| 09/07/1999 | CA2147881C Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases |
| 09/07/1999 | CA2098944C Novel pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 09/07/1999 | CA2016646C Arylsulphonamides |
| 09/07/1999 | CA2014008C Benzimidazoles, medicaments containing these compounds and processes for their preparation |
| 09/07/1999 | CA1340722C Pharmaceutical composition for the treatment of high blood pressure |
| 09/02/1999 | WO1999043809A2 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | WO1999043672A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | WO1999043663A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | WO1999043657A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 09/02/1999 | WO1999043354A2 Method for treating painful conditions of the anal region and compositions therefor |
| 09/02/1999 | WO1999043334A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/02/1999 | WO1999043325A1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance |
| 09/02/1999 | WO1999043310A2 20-hete antagonists and agonists |
| 09/02/1999 | WO1999043210A1 Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist |
| 09/02/1999 | WO1999033841A3 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 09/02/1999 | WO1999030720A8 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 09/02/1999 | WO1999024460A3 Dipeptide nitriles |
| 09/02/1999 | WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth |
| 09/02/1999 | WO1999015548B1 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | CA2322163A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | CA2321642A1 N-¬(substituted five-membered di- or triaza diunsaturated ring)carbonyl|guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | CA2321142A1 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | CA2318778A1 Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0938899A2 Agent for improving the blood circulation |
| 09/01/1999 | EP0938505A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 09/01/1999 | EP0938500A1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/01/1999 | EP0938494A1 Inhibitors of protein farnesyl transferase |
| 09/01/1999 | EP0938489A1 New phosphonates, process for preparing the same and medicaments |
| 09/01/1999 | EP0938480A1 Substituted tetrahydro-1,3,5-triazin-2 1h]-thiones as anti-atherosclerotic agents |
| 09/01/1999 | EP0938477A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938324A1 Pharmaceutical composition containing nitric oxide |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0938303A1 Antioxidant-induced apoptosis in vascular smooth muscle cells |
| 09/01/1999 | EP0938258A1 Emulsions of perfluoro compounds as solvents for nitric oxide (no) |
| 09/01/1999 | EP0700301B1 Peptides and compounds that bind to elam-1 |
| 09/01/1999 | EP0672055B1 Neuropeptide y antagonists |
| 09/01/1999 | EP0643780B2 Multiple solvent cleaning system |
| 09/01/1999 | CN1227560A Thienopyrimidines |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227501A Long-acting drugs and pharmaceutical compositions comprising them |
| 09/01/1999 | CN1227494A Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cell |
| 09/01/1999 | CN1227225A Thiazole derivatives |
| 09/01/1999 | CN1227100A Compound preparation for curing and preventing thrombosis and apoplexy and its preparing method |
| 09/01/1999 | CN1227099A Novel treatment agent |
| 09/01/1999 | CN1044910C Indole derivatives |
| 09/01/1999 | CN1044909C 吲哚衍生物 Indole derivatives |
| 09/01/1999 | CN1044905C Anellated dihydropyridines and its producing method and medicinal composition comprising them |
| 09/01/1999 | CN1044897C Large potassium bicarbonate crystals and process for preparation thereof |
| 08/31/1999 | US5945577 Nuclear transfer units for cells |
| 08/31/1999 | US5945456 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 08/31/1999 | US5945440 Indolocarbazole imides and the use thereof |
| 08/31/1999 | US5945433 Humans and veterinary science |
| 08/31/1999 | US5945426 Derivatives of pyrimidine for treating acute cerebrovascular disorders |
| 08/31/1999 | US5945408 Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors |
| 08/31/1999 | US5945310 DNA encoding members of the IL-1 family, IL-1 delta |
| 08/31/1999 | US5945308 Polynucleotide |
| 08/31/1999 | US5945123 Determining known pharacokinetic parameters of therapeutical substance, number of doses to be administered during 24 hours and determining time at which dose will be adminstered by considering both schedule and physiological anamolies |
| 08/31/1999 | US5944021 Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema |
| 08/31/1999 | CA2183315C Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/31/1999 | CA2183314C Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/31/1999 | CA2145835C Hydroxamic acid derivatives with tricyclic substitution |
| 08/26/1999 | WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR |
| 08/26/1999 | WO1999042601A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 08/26/1999 | WO1999042574A1 Sequences of an ih ionic channel and the use thereof |
| 08/26/1999 | WO1999042485A1 Mucilage, a g-protein-coupled receptor |
| 08/26/1999 | WO1999042456A2 Novel compounds and their use as positive ampa receptor modulators |
| 08/26/1999 | WO1999042453A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 08/26/1999 | WO1999042444A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 08/26/1999 | WO1999042443A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 08/26/1999 | WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | WO1999042427A1 E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof |
| 08/26/1999 | WO1999042105A1 Epimorphian compound and its use |
| 08/26/1999 | WO1999042102A1 Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 08/26/1999 | WO1999042101A1 Dietary control of arachidonic acid metabolism |
| 08/26/1999 | WO1999042089A2 Use of thiadiazolo[4,3-a]pyridine derivatives |
| 08/26/1999 | WO1999033825A8 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositons containing them |
| 08/26/1999 | WO1999028342A3 Low-voltage activated calcium channel compositions and methods |
| 08/26/1999 | WO1999024571A3 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 08/26/1999 | WO1999024421A8 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 08/26/1999 | DE19810998C1 New metal-containing ribonucleotide proteins with nuclease and phosphatase activities, used e.g. for cell-selective inhibition of protein synthesis and inhibition of tumors |
| 08/26/1999 | DE19807423A1 New isoindolone derivatives useful as soluble guanylate cyclase activators for treating cardiovascular disorders, asthma, renal insufficiency, diabetes, cirrhosis or cognitive dysfunction |
| 08/26/1999 | CA2321182A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 08/26/1999 | CA2321052A1 Process for the obtaining of hmg-coa reductase inhibitors of high purity |
| 08/26/1999 | CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |